Figure 4.
Hazard ratios comparing intensive to standard glycemia arm assignment for each microvascular outcome utilizing data until transition of intensive glycemia arm to standard therapy. Hazard ratios adjusted for baseline clinical cardiovascular disease history and second trial treatment arm assignment. Horizontal bars represent 95% confidence intervals.